Research Associate II - Hematologic Malignancies jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 5 hours ago

Research Associate II - Hematologic Malignancies

City of Hope is a leading research institution dedicated to innovative approaches in predicting, preventing, and curing diseases. The Research Associate II will conduct independent research projects, supervise interns, and write research papers while collaborating with internal and external partners.

AssociationEducationHealth Care
check
Comp. & Benefits

Responsibilities

Conduct the research project independently in one of listed research areas
Supervise research intern in the lab
Write the research papers, protocols and organize data for grant application
Excellent communication skills, as the basis of internal or external collaboration

Qualification

Molecular biologyImmunologySequencingProtein structural data analysisInduced pluripotent stem cells (iPSC)Fluency in EnglishCommunication skillsTeam player

Required

Bachelor's degree
Two years related research/ laboratory experience with a Bachelor's degree or one year related research/ laboratory experience with a Master's degree

Preferred

M.S. with a background and profound knowledge in the field of either molecular biology, immunology, experience in sequencing, or protein structural data analysis
Experience in induced pluripotent stem cell (iPSC) establishment possesses a deep understanding of the entire reprogramming process, from the sourcing of somatic cells to the final characterization and banking of high-quality, pluripotent lines. This expertise involves mastering numerous technical challenges, staying current with diverse reprogramming methods, and implementing rigorous quality control throughout the workflow
Literature knowledge of one of the research areas mentioned above
Strong team player with excellent communication skills and fluency in English, both spoken and written

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase